labetalol has been researched along with Pulmonary Fibrosis in 2 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A diffuse interstitial pulmonary fibrosis occurred in a 74-year-old woman treated for ten years with labetalol for systemic hypertension." | 3.69 | [Fibrosing pneumopathy caused by labetalol]. ( Chabot, F; Delorme, N; Kheir, A; Polu, JM, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kheir, A | 1 |
| Chabot, F | 1 |
| Delorme, N | 1 |
| Polu, JM | 1 |
| Vacher, D | 1 |
| Aumaître, O | 1 |
| Mignot, P | 1 |
| Lavarenne, J | 1 |
| Molina, C | 1 |
2 other studies available for labetalol and Pulmonary Fibrosis
| Article | Year |
|---|---|
[Fibrosing pneumopathy caused by labetalol].
Topics: Adrenergic beta-Antagonists; Aged; Female; Humans; Labetalol; Pulmonary Fibrosis | 1996 |
[Drug-induced allergic alveolitis and Parsonage-Turner syndrome in a patient treated with labetalol].
Topics: Drug Hypersensitivity; Humans; Labetalol; Male; Middle Aged; Nervous System Diseases; Pulmonary Fibr | 1987 |